Published by Josh White on 24th April 2025
(Sharecast News) - Hikma Pharmaceuticals reaffirmed its full-year guidance on Thursday following a solid start to 2025, supported by stable trading across its three core divisions.
URL: http://www.digitallook.com/dl/news/story/35032204/...